Get the Stockscreener App
2.14
6.96%
-0.16
After Hours:
2.10
-0.04
-1.87%
Opus Genetics Inc stock is traded at $2.14, with a volume of 558.51K.
It is down -6.96% in the last 24 hours and up +13.83% over the past month.
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.
See More
Previous Close:
$2.30
Open:
$2.315
24h Volume:
558.51K
Relative Volume:
1.57
Market Cap:
$128.20M
Revenue:
$8.38M
Net Income/Loss:
$-27.19M
P/E Ratio:
-1.9633
EPS:
-1.09
Net Cash Flow:
$-13.59M
1W Performance:
+7.00%
1M Performance:
+13.83%
6M Performance:
+124.22%
1Y Performance:
+81.36%
1-Day Range:
$2.10
$2.37
1-Week Range:
$1.899
$2.37
52-Week Range:
$0.65
$2.37
Opus Genetics Inc Stock (IRD) Company Profile
Name
Opus Genetics Inc
Sector
Industry
Phone
248-681-9815
Address
8 DAVIS DRIVE, DURHAM
Compare IRD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRD
Opus Genetics Inc
|
2.14 | 137.79M | 8.38M | -27.19M | -13.59M | -1.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Opus Genetics Inc Stock (IRD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Initiated | Wedbush | Outperform |
| Oct-16-25 | Initiated | Chardan Capital Markets | Buy |
| Apr-11-25 | Initiated | Craig Hallum | Buy |
| Nov-13-24 | Resumed | H.C. Wainwright | Buy |
Opus Genetics Inc Stock (IRD) Latest News
Opus Genetics (IRD) Gains Attention on Good Morning America - GuruFocus
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness - Yahoo Finance
Is Opus Genetics Inc. stock a buy on dipsJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
What the charts say about Opus Genetics Inc. todayWeekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
What candlestick patterns are forming on Opus Genetics Inc.2025 Trade Ideas & Daily Oversold Stock Bounce Ideas - newser.com
Can Opus Genetics Inc. stock hit analyst price targetsWatch List & Long Hold Capital Preservation Plans - newser.com
Identifying reversal signals in Opus Genetics Inc.2025 Technical Overview & Safe Capital Growth Stock Tips - newser.com
Is Opus Genetics Inc. stock ready for a breakout2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com
Can Opus Genetics Inc. (R3X1) stock sustain institutional flowsWeekly Trend Recap & Technical Analysis for Trade Confirmation - newser.com
Will Opus Genetics Inc. stock continue upward momentumMarket Growth Report & Technical Analysis for Trade Confirmation - newser.com
Applying chart zones and confluence areas to Opus Genetics Inc.Weekly Trading Summary & Fast Entry Momentum Trade Alerts - newser.com
Can Opus Genetics Inc. hit a new high this monthOil Prices & Low Drawdown Investment Strategies - newser.com
Using Ichimoku Cloud for Opus Genetics Inc. technicals2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-03 00:10:07 - newser.com
Will Opus Genetics Inc. stock benefit from infrastructure spending2025 Price Targets & Smart Allocation Stock Reports - newser.com
Price action breakdown for Opus Genetics Inc.2025 Trade Ideas & Technical Buy Zone Confirmations - newser.com
Is Opus Genetics Inc. (R3X1) stock ideal for retirement investorsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com
Is Opus Genetics Inc a good long term investmentSupport and Resistance Levels & Stay Invested. Stay Smart. - earlytimes.in
Does Opus Genetics Inc. stock trade at a discount to peersQuarterly Risk Review & Smart Money Movement Alerts - newser.com
How to use a screener to detect Opus Genetics Inc. breakoutsPortfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Why Opus Genetics Inc. stock is in analyst buy zonePortfolio Growth Summary & Momentum Based Trading Signals - newser.com
What MACD trends signal for Opus Genetics Inc. (R3X1) stockJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is Opus Genetics Inc. stock attractive for hedge fundsJuly 2025 Highlights & Real-Time Buy Signal Notifications - newser.com
Can Opus Genetics Inc. (R3X1) stock attract ESG investmentsBond Market & Weekly Return Optimization Alerts - newser.com
With Opus Genetics Up 16%, Insider Buyers Count Their Returns - Yahoo Finance
Q3 Earnings Forecast for Opus Genetics Issued By Wedbush - MarketBeat
Is Opus Genetics Inc. stock a safe haven assetRecession Risk & High Return Stock Watch Alerts - newser.com
Published on: 2025-11-01 00:17:29 - newser.com
Opus Genetics, Inc. (NASDAQ:IRD) Sees Large Increase in Short Interest - MarketBeat
Opus Genetics (NASDAQ:IRD) Trading Up 2.6%Still a Buy? - MarketBeat
Opus Genetics (IRD) Price Target Decreased by 15.00% to 6.94 - MSN
Opus Genetics Inc Stock (IRD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):